Related Experiment Video
Updated: Jul 10, 2026

07:44
An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants
Published on: May 22, 2020
MECP2 mutations in Serbian Rett syndrome patients
A Djarmati1, V Dobricić, M Kecmanović
1Faculty of Biology, University of Belgrade, Belgrade, Serbia. ana.djarmati@neuro.uni-luebeck.de
Acta Neurologica Scandinavica
|November 8, 2007
Summary
MECP2 mutations cause Rett syndrome in 79% of Serbian patients, including novel mutations. This study details the MECP2 mutational spectrum in Serbian Rett syndrome patients, enhancing genotype-phenotype understanding.
Area of Science:
- Genetics
- Neurodevelopmental Disorders
- Molecular Biology
Background:
- Rett syndrome is a severe X-linked dominant neurodevelopmental disorder.
- Mutations in the MECP2 gene are strongly associated with Rett syndrome.
- Understanding MECP2 mutations is crucial for diagnosis and treatment.
Purpose of the Study:
- To investigate the spectrum and frequency of MECP2 mutations in Serbian Rett syndrome patients.
- To identify novel MECP2 mutations.
- To explore genotype-phenotype correlations in this population.
Main Methods:
- Screening of the MECP2 coding region using single-strand conformation polymorphism and sequencing.
- Development and application of a novel quantitative PCR method for detecting gene dosage alterations.
- Analysis of 24 Serbian Rett syndrome patients and 41 family members.
Main Results:
- MECP2 mutations were identified in 79% of patients (19 out of 24).
- Five novel mutations (one nonsense, one duplication, three deletions) were discovered.
- Fourteen known disease-causing mutations and one polymorphism were also detected.
Conclusions:
- This study provides the first genetic analysis of Rett syndrome in Serbian patients.
- It describes the MECP2 mutational and phenotypic spectrum within this population.
- Findings contribute to a better understanding of genotype-phenotype correlations in Rett syndrome.
Related Concept Videos
The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Master Transcription Regulators
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Non-LTR Retrotransposons
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...

